BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bustad HJ, Kallio JP, Vorland M, Fiorentino V, Sandberg S, Schmitt C, Aarsand AK, Martinez A. Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators. Int J Mol Sci 2021;22:E675. [PMID: 33445488 DOI: 10.3390/ijms22020675] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Liang L, Meng H, Wu H, Zhao J. Genetic Analysis and Prenatal Diagnosis of Acute Intermittent Porphyria Caused by Novel Classical Splicing Variant in the Insertion Region of 29-Residue Specific to Human HMBS Protein.. [DOI: 10.21203/rs.3.rs-2431452/v1] [Reference Citation Analysis]
2 Menezes PR, Trufen CEM, Lichtenstein F, Pellegrina DVDS, Reis EM, Onuki J. Transcriptome profile analysis reveals putative molecular mechanisms of 5-aminolevulinic acid toxicity. Arch Biochem Biophys 2023;738:109540. [PMID: 36746260 DOI: 10.1016/j.abb.2023.109540] [Reference Citation Analysis]
3 Ramzan A, Cao JJL, Frazer JS, Stein P, Ahmad S. A Case of Acute Intermittent Porphyria Leading to Severe Disability in a Young 21-Year-Old Female. Cureus 2023;15:e34757. [PMID: 36909084 DOI: 10.7759/cureus.34757] [Reference Citation Analysis]
4 Savino M, Guida CC, Nardella M, Murgo E, Augello B, Merla G, De Cosmo S, Savino AF, Tarquini R, Cei F, Aucella F, Mazzoccoli G. Circadian Genes Expression Patterns in Disorders Due to Enzyme Deficiencies in the Heme Biosynthetic Pathway. Biomedicines 2022;10. [PMID: 36551954 DOI: 10.3390/biomedicines10123198] [Reference Citation Analysis]
5 Jericó D, Córdoba KM, Sampedro A, Jiang L, Joucla G, Cabanne C, Lanciego JL, Martini PGV, Berraondo P, Ávila MA, Fontanellas A. Recent Insights into the Pathogenesis of Acute Porphyria Attacks and Increasing Hepatic PBGD as an Etiological Treatment. Life (Basel) 2022;12. [PMID: 36430993 DOI: 10.3390/life12111858] [Reference Citation Analysis]
6 Vachiravit Sriprakoon, Chalisa Ittagornpunth, Nakorn Puapaiboon, Aekasit Bunyahathaipat, Punnapat Piriyanon, Sookkasem Khositseth, Kitiwan Rojnueangnit. Acute Intermittent Porphyria: Complete Phenotype in a Patient with p.Arg173Trp Variant in Thailand. Am J Case Rep 2022;23. [PMID: 36329616 DOI: 10.12659/AJCR.937695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Elsayed Abed, Omer M. Saeed, Basem Abd El-Hamid, Mohamed A. Elsayed, Heba Dawoud, Nahla Mohamed Heikal, Ahmed Hanei Elshafie, Aya Hagar, Hossam Emam, Ahmed Farag El-adawey, Abdel-Ghaffar Fayed, Ahmed Hassan Elsheshiny, Mahmoud Galal Ahmed. Acute Intermittent Porphyria as a Rare Challenging Neuro-Metabolic Disease; a Case Report. Arch Acad Emerg Med 2022;10:e74. [PMID: 36381968 DOI: 10.22037/aaem.v10i1.1780] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Li A. Wood’s lamp urinary examination in acute intermittent porphyria. QJM: An International Journal of Medicine 2022;115:492-493. [DOI: 10.1093/qjmed/hcac100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Petrides PE. Therapy Follows Diagnosis: Old and New Approaches for the Treatment of Acute Porphyrias, What We Know and What We Should Know. Diagnostics 2022;12:1618. [DOI: 10.3390/diagnostics12071618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Francesca G, Nicolli A, Colaiocco A, Di Pierro E, Graziadei G. Psychological Aspect and Quality of Life in Porphyrias: A Review. Diagnostics 2022;12:1193. [DOI: 10.3390/diagnostics12051193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Gomez-Gomez A, Aguilera P, Langohr K, Casals G, Pavon C, Marcos J, To-Figueras J, Pozo OJ. Evaluation of Metabolic Changes in Acute Intermittent Porphyria Patients by Targeted Metabolomics. Int J Mol Sci 2022;23:3219. [PMID: 35328641 DOI: 10.3390/ijms23063219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Morren MA, Legius E, Giuliano F, Hadj-Rabia S, Hohl D, Bodemer C. Challenges in Treating Genodermatoses: New Therapies at the Horizon. Front Pharmacol 2021;12:746664. [PMID: 35069188 DOI: 10.3389/fphar.2021.746664] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Ortega AJ, Cherukuri S, Kalas MA, Lee B, Guzman J, Robles A, Zuckerman MJ, Al-bayati I. A Perfect Storm: Abdominal Pain and Ileus Explained by Acute Intermittent Porphyria Caused by Prehospitalization and Intrahospitalization Factors. Journal of Investigative Medicine High Impact Case Reports 2022;10:232470962211092. [DOI: 10.1177/23247096221109206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 de Souza PVS, Badia BML, Farias IB, Pinto WBVR, Oliveira ASB. Acute Hepatic Porphyria: Pathophysiological Basis of Neuromuscular Manifestations. Front Neurosci 2021;15:715523. [PMID: 34646118 DOI: 10.3389/fnins.2021.715523] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Zhang Y, Xiao H, Xiong Q, Wu C, Li P. Two Novel Hydroxymethylbilane Synthase Splicing Mutations Predispose to Acute Intermittent Porphyria. Int J Mol Sci 2021;22:11008. [PMID: 34681668 DOI: 10.3390/ijms222011008] [Reference Citation Analysis]
16 Petrides PE, Klein M, Schuhmann E, Torkler H, Molitor B, Loehr C, Obermeier Z, Beykirch MK. Severe homocysteinemia in two givosiran-treated porphyria patients: is free heme deficiency the culprit? Ann Hematol 2021;100:1685-93. [PMID: 34050373 DOI: 10.1007/s00277-021-04547-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
17 Syed YY. Givosiran: A Review in Acute Hepatic Porphyria. Drugs 2021;81:841-8. [PMID: 33871817 DOI: 10.1007/s40265-021-01511-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]